The weekend after Christmas is often one of the busiest for U.S. ski resorts, but the chairs aren’t spinning at Telluride ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...
TODAY, the world marks World Sickle Cell Day, a moment to draw attention to one of the country’s most pressing yet often overlooked health challenges—sickle cell disease (SCD). It is a condition ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).
The Avid Outdoorsman on MSN
Gun makers are shifting designs in response to real-world feedback
Gun makers are quietly rewriting their playbooks as real-world shooters, new buyers and regulators push the industry toward ...
A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.
NGOs laud NASS over Sickle Cell Centres Bill, bankroll free clinic for 400 warriors The CrimsonBow Sickle Cell Initiative and Rabiu Olowo Foundation have applauded the Senate for prioritising the ...
The CrimsonBow Sickle Cell Initiative has applauded the Senate for prioritising the welfare of persons living with Sickle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback